181 results
Page 4 of 10
S-8 POS
EX-23.2
ubvewot
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:23pm
S-8 POS
4pbaqondnrbjv59w
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:22pm
S-8 POS
EX-23.2
m2zulfd1h 53vrxhivv
9 Aug 21
Registration of securities for employees (post-effective amendment)
5:22pm
S-8
5jn6z20
9 Aug 21
Registration of securities for employees
4:56pm
S-8
EX-23.2
jkeyu4kb4q5qf
9 Aug 21
Registration of securities for employees
4:56pm
8-K
EX-1.1
a36ej0i3wk7qw1bj4
9 Aug 21
Entry into a Material Definitive Agreement
4:48pm
424B5
91sv 23r1p5
9 Aug 21
Prospectus supplement for primary offering
4:43pm
8-K
7z872g9z 5tqwg
22 Jul 21
Ocular Therapeutix™ Announces Second Quarter 2021 Preliminary Net Product Revenue of $11.7 Million
4:33pm
8-K
wj4g8bxng1p1hg7yajl8
22 Jun 21
Departure of Directors or Certain Officers
4:14pm
8-K
EX-10.1
nnon06zjmbe3go5
4 Jun 21
Entry into a Material Definitive Agreement
4:34pm
DEFA14A
01f5m
29 Apr 21
Additional proxy soliciting materials
4:18pm
8-K
efpjsbooto f94763n01
29 Apr 21
Results of Operations and Financial Condition
6:31am
PRE 14A
j4nso88 liw
13 Apr 21
Preliminary proxy
5:07pm
S-8
EX-23.2
xl8 hcej1xdua
11 Mar 21
Registration of securities for employees
4:25pm
S-8
1g3wkvld4t gmwnumv
11 Mar 21
Registration of securities for employees
4:25pm